KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Bristol Myers Squibb (BMY) Shareholder's Equity (2009 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shareholder's Equity (Qtr)
1	Novartis Ag	107,124,802.25 Bn	107,124,802.25 Bn	-	-
2	Eli Lilly	969.00 Bn	963.72 Bn	16.22 Bn	31.20 Bn
3	Johnson & Johnson	539.46 Bn	517.41 Bn	15.96 Bn	81.19 Bn
4	AbbVie	376.92 Bn	367.57 Bn	10.78 Bn	-6.66 Bn
5	Merck	285.00 Bn	279.35 Bn	12.09 Bn	45.88 Bn
6	Amgen	177.58 Bn	165.55 Bn	5.87 Bn	9.19 Bn
7	Gilead Sciences	163.22 Bn	155.50 Bn	5.52 Bn	23.52 Bn
8	Pfizer	145.86 Bn	133.09 Bn	-1.21 Bn	90.10 Bn
9	Bristol Myers Squibb	111.90 Bn	101.44 Bn	8.07 Bn	20.07 Bn
10	Gsk	88.34 Bn	83.66 Bn	-	21.78 Bn

Historic Data

Download Data 🔒

Date	Value
Mar 31, 2026	20.07 Bn
Dec 31, 2025	18.47 Bn
Sep 30, 2025	18.60 Bn
Jun 30, 2025	54.00 Mn
Mar 31, 2025	292.00 Mn
Dec 31, 2024	14.91 Bn
Sep 30, 2024	292.00 Mn
Jun 30, 2024	292.00 Mn
Mar 31, 2024	-43.70 Bn
Dec 31, 2023	-1.55 Bn
Sep 30, 2023	28.22 Bn
Jun 30, 2023	-39.68 Bn
Mar 31, 2023	292.00 Mn
Dec 31, 2022	-1.28 Bn
Sep 30, 2022	-841.00 Mn
Jun 30, 2022	-35.29 Bn
Mar 31, 2022	65.00 Mn
Dec 31, 2021	23.82 Bn
Sep 30, 2021	44.29 Bn
Jun 30, 2021	292.00 Mn
Mar 31, 2021	43.85 Bn
Dec 31, 2020	-1.84 Bn
Sep 30, 2020	50.23 Bn
Jun 30, 2020	49.16 Bn
Mar 31, 2020	49.98 Bn
Dec 31, 2019	43.71 Bn
Sep 30, 2019	17.75 Bn
Jun 30, 2019	16.15 Bn
Mar 31, 2019	15.32 Bn
Dec 31, 2018	96.00 Mn
Sep 30, 2018	13.75 Bn
Jun 30, 2018	12.42 Bn
Mar 31, 2018	12.91 Bn
Dec 31, 2017	11.85 Bn
Sep 30, 2017	14.91 Bn
Jun 30, 2017	14.82 Bn
Mar 31, 2017	14.54 Bn
Dec 31, 2016	16.18 Bn
Sep 30, 2016	15.78 Bn
Jun 30, 2016	15.08 Bn
Mar 31, 2016	14.55 Bn
Dec 31, 2015	14.42 Bn
Sep 30, 2015	15.27 Bn
Jun 30, 2015	15.29 Bn
Mar 31, 2015	15.69 Bn
Dec 31, 2014	14.85 Bn
Sep 30, 2014	15.20 Bn
Jun 30, 2014	15.38 Bn
Mar 31, 2014	15.53 Bn
Dec 31, 2013	15.15 Bn
Sep 30, 2013	14.71 Bn
Jun 30, 2013	14.37 Bn
Mar 31, 2013	13.70 Bn
Dec 31, 2012	13.64 Bn
Sep 30, 2012	13.90 Bn
Jun 30, 2012	15.81 Bn
Mar 31, 2012	16.25 Bn
Dec 31, 2011	15.87 Bn
Sep 30, 2011	16.44 Bn
Jun 30, 2011	16.15 Bn
Mar 31, 2011	15.90 Bn
Dec 31, 2010	15.71 Bn
Dec 31, 2009	14.79 Bn
Sep 30, 2009	14.52 Bn
Jun 30, 2009	13.94 Bn